Literature DB >> 20409976

Particulate matter, air pollution, and blood pressure.

Robert D Brook1, Sanjay Rajagopalan.   

Abstract

A short-term increase in fine particulate matter air pollution (PM(2.5)) concentration increases the risk for myocardial infarctions, strokes, and heart failure exacerbations. An important mechanism likely contributing to these associations is an elevation in arterial blood pressure (BP). Exposure to ambient PM(2.5) even at present-day concentrations can increase BP within a period of a few days while long-term exposure might also promote the development of chronic hypertension. Controlled human and animal experiments have corroborated the veracity of these findings and elucidated plausible biological mechanisms. PM(2.5) deposition within the pulmonary tree is capable of rapidly triggering autonomic nervous system imbalance, thereby increasing BP within minutes of inhalation. In addition, fine particles can instigate a systemic pro-inflammatory response over a more prolonged period of exposure. Higher circulating levels of activated immune cells and inflammatory cytokines could consequently cause vascular endothelial dysfunction leading to an imbalance in vascular homeostatic responses. Indeed, chronic PM(2.5) exposure augments pro-vasoconstrictive pathways while blunting vasodilator capacity. Finally, certain particle constituents (e.g., metals, organic compounds, and ultra-fine particles) might also be capable of reaching the systemic circulation upon inhalation and thereafter directly impair vascular function. At the molecular level, the generation of oxidative stress with the consequent up-regulation of redox sensitive pathways appears to be a common and fundamental mechanism involved in the instigation of these pro-hypertensive responses. Due to the ubiquitous, continuous and often involuntary nature of exposure, PM(2.5) may be an important and under-appreciated worldwide environmental risk factor for increased arterial BP.

Entities:  

Year:  2009        PMID: 20409976     DOI: 10.1016/j.jash.2009.08.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  98 in total

1.  Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution.

Authors:  Loren E Wold; Zhekang Ying; Kirk R Hutchinson; Markus Velten; Matthew W Gorr; Christina Velten; Dane J Youtz; Aixia Wang; Pamela A Lucchesi; Qinghua Sun; Sanjay Rajagopalan
Journal:  Circ Heart Fail       Date:  2012-06-01       Impact factor: 8.790

Review 2.  Impact of particulate matter exposition on the risk of ischemic stroke: epidemiologic evidence and putative mechanisms.

Authors:  Daniel von Bornstädt; Alexander Kunz; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-04       Impact factor: 6.200

3.  Myocardial infarction and occupational exposure to motor exhaust: a population-based case-control study in Sweden.

Authors:  Anna Ilar; Marie Lewné; Nils Plato; Johan Hallqvist; Magnus Alderling; Carolina Bigert; Christer Hogstedt; Per Gustavsson
Journal:  Eur J Epidemiol       Date:  2014-07-01       Impact factor: 8.082

4.  Exposure to air pollution is associated with adverse cardiopulmonary health effects in international travellers.

Authors:  M J Ruzmyn Vilcassim; George D Thurston; Lung-Chi Chen; Chris C Lim; Eric Saunders; Yixin Yao; Terry Gordon
Journal:  J Travel Med       Date:  2019-06-11       Impact factor: 8.490

5.  Are Internalized Metals a Long-term Health Hazard for Military Veterans?

Authors:  John F Kalinich; Christine E Kasper
Journal:  Public Health Rep       Date:  2016-10-13       Impact factor: 2.792

Review 6.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

7.  Ambient Air Pollution and Risk of Gestational Hypertension.

Authors:  Yeyi Zhu; Cuilin Zhang; Danping Liu; Sandie Ha; Sung Soo Kim; Anna Pollack; Pauline Mendola
Journal:  Am J Epidemiol       Date:  2017-08-01       Impact factor: 4.897

8.  Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution.

Authors:  Robert D Brook; Xiaohua Xu; Robert L Bard; J Timothy Dvonch; Masako Morishita; Niko Kaciroti; Qinghua Sun; Jack Harkema; Sanjay Rajagopalan
Journal:  Sci Total Environ       Date:  2012-08-15       Impact factor: 7.963

9.  Association of Carbon Monoxide exposure with blood pressure among pregnant women in rural Ghana: Evidence from GRAPHS.

Authors:  Ashlinn K Quinn; Kenneth Ayuurebobi Ae-Ngibise; Darby W Jack; Ellen Abrafi Boamah; Yeetey Enuameh; Mohammed Nuhu Mujtaba; Steven N Chillrud; Blair J Wylie; Seth Owusu-Agyei; Patrick L Kinney; Kwaku Poku Asante
Journal:  Int J Hyg Environ Health       Date:  2015-11-10       Impact factor: 5.840

10.  Extreme Air Pollution Conditions Adversely Affect Blood Pressure and Insulin Resistance: The Air Pollution and Cardiometabolic Disease Study.

Authors:  Robert D Brook; Zhichao Sun; Jeffrey R Brook; Xiaoyi Zhao; Yanping Ruan; Jianhua Yan; Bhramar Mukherjee; Xiaoquan Rao; Fengkui Duan; Lixian Sun; Ruijuan Liang; Hui Lian; Shuyang Zhang; Quan Fang; Dongfeng Gu; Qinghua Sun; Zhongjie Fan; Sanjay Rajagopalan
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.